Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 29 Jun 2003):

Comparison of Pueraria lobata with hormone replacement therapy in treating the adverse health consequences of menopause.

Full Abstract

OBJECTIVE:
Pueraria lobata (PL) is used as a traditional Chinese herbal remedy for menopausal symptoms, as well as an ingredient in preparations for conditions affecting menopausal women, such as osteoporosis, coronary heart disease, and some hormone-dependent cancers. The scientific basis for its action may be its action as a phytoestrogen.

DESIGN:
To examine the effects of PL in comparison with hormone replacement therapy (HRT) on lipid profile, sex hormone levels, bone turnover markers, and indices of cognitive function. For the study, 127 community-living, postmenopausal women aged 50 to 65 years were randomized to receive HRT (n = 43), PL (equivalent to 100 mg isoflavone; n = 45), or no treatment (n = 39) for 3 months. The following measurements were carried out at baseline and after 3 months for all participants:
menopausal symptoms questionnaire; neuropsychological tests covering memory, attention, motor speed, and word-finding ability; quality of life (SF36); lipid profile; urinary deoxypyridinoline; dietary phytoestrogen intake and urinary phytoestrogen; estradiol; follicle-stimulating hormone; and luteinizing hormone.

RESULTS:
Only participants in the HRT group showed a mean reduction in cholesterol and low-density lipoprotein cholesterol that was significantly different from that of the control group. No significant changes in lipid profile or follicle-stimulating hormone and luteinizing hormone were observed in the PL group compared with the controls. However, both the HRT and PL groups showed an improvement in Mini-Mental State Examination score and attention span compared with the case of participants receiving no treatment. HRT and PL had different effects on cognitive function; HRT improved delayed recall, whereas flexible thinking seemed improved in the PL group.

CONCLUSIONS:
This study was unable to demonstrate a scientific basis for the use of PL for improving the health of postmenopausal women in general. However, the effect of PL on cognitive function deserves further study.

 

Learn Faster Today      Improve your study skills

Author information

Author/s: Woo, Jean (J); Lau, Edith (E); Ho, Suzanne C (SC); Cheng, Francis (F); Chan, Cynthia (C); Chan, Agnes S Y (AS); Haines, Christopher J (CJ); Chan, Thomas Y K (TY); Li, Martin (M); Sham, Aprille (A);

Affiliation: Department of Community and Family Medicine, The Chinese University of Hong Kong, Hong Kong. jeanwoowong(-atsign-)cuhk.edu.hk

Journal and publication information

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Journal: Menopause (New York, N.Y.) (Menopause), published in United States. (Language: eng)

Reference: -2003 Jul-Aug; vol 10 (issue 4) : pp 352-61

Dates: Created 2003/07/09; Completed 2003/10/07; Revised 2006/11/15;

PMID: 12851519, status: MEDLINE (last retrieval date: 11/6/2008)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article (including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Cholesterol, LDL (0) ; Estrogens, Conjugated (USP) (0) ; Estrogens, Non-Steroidal (0) ; Isoflavones (0) ; Phytoestrogens (0) ; Plant Preparations (0) ; Progesterone Congeners (0) ; Cholesterol (57-88-5) ; Medroxyprogesterone 17-Acetate (71-58-9)

Related articles

This article has not been indexed for related articles as yet, however you can still use the live related article search links below.

See 100+ related articles.

See a large map of 100+ related articles.

© Advanogy.com 2003-2008 (ACN 104 198 263) - All rights reserved. Terms of Use | Contact Us | Index